For all their promise, GLP-1 and dual GIP/GLP-1 receptor agonists have raised more questions, particularly regarding their long-term safety implications
Mandrika and colleagues (Biochem Pharmacol, 2001, PMID 11239505) examined melanocortin peptides on NF-B DNA binding in RAW 264.7 macrophage-like cells and reported evidence for dual mechanisms of action, and Kannengiesser and colleagues (Inflamm Bowel Dis, 2008, PMID 18092346) reported effects in murine colitis models that were partly independent of MC1R
By months four through six, the external changes become obvious
Learn more about how we can help you here
30 Jun 2026 QaseemA, ObleyAJ, Shamilyan T, Hicks LA, et.al.,Clinical Guidelines Committee ofthe American College of Physicians